Skip to main content

LATEST UPDATES: Racial Justice | Tracking COVID-19 (coronavirus)

Scripps Receives $129 Million NIH Grant For HIV Vaccine Research

This April 12, 2011 electron microscope image made available by the National ...

Credit: NIAID

Above: This April 12, 2011 electron microscope image made available by the National Institute of Allergy and Infectious Diseases shows an H9 T cell, blue, infected with the human immunodeficiency virus (HIV), yellow.

Scripps Research Institute received a $129 million grant Wednesday from the National Institutes of Health to move forward with developing a vaccine for the human immunodeficiency virus, or HIV.

Scripps researchers are leading an international research effort and will be receiving around half of the grant money over the next several years.

By Reporter Shalina Chatlani

The vaccination research is part of an international effort to target HIV.

HIV is difficult to deal with because there are just so many strains of the virus. That’s according to immunologist Dennis Burton, one of the lead researchers from Scripps.

In his lab, Burton works with other scientists around the world to create a vaccine that can induce different kinds of antibodies or proteins in the blood that fight a virus.

"We have this variability problem, so many strains of the virus. We need particular types of antibodies that will take out all these strains," Burton said. "Inducing that by vaccination proves to be difficult. So we have had to come out with some very new strategies."

Burton said other vaccinations have been narrow in the strains they can fight, or the vaccines simply have not worked well. So they are trying to create something more general.

"And that’s not really been developed to date. There have been other attempts to make HIV vaccines that have relied on different mechanisms mostly they’ve been unsuccessful or possibly marginally successful," Burton said.

The vaccine will be geared toward children, Burton said, so they can develop an immunity to the virus. The hope is to develop an actual vaccine that can be tested on humans.

San Diego News Matters podcast branding

A local archive space in University Heights is home to much of San Diego’s LGBTQ history. Hear what’s inside. Plus, despite a growing Latino middle class, California families face hurdles getting there; Scripps researchers take the lead in a $129 million grant for HIV vaccine research; and a teenage girl from Alpine meets the kidney donor who saved her life. ...

Aired: July 11, 2019 | Transcript

  • Don’t have time to keep up on the latest news? We’ve got you covered with a mid-week check-in every Wednesday afternoon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Photo of Shalina Chatlani

Shalina Chatlani
Science and Technology Reporter

opening quote marksclosing quote marksI cover all things science and technology — from the biotech industry in San Diego to rooftop solar energy on new homes. I'm interested in covering the human side of science and technology, like barriers to entry for people of color or gender equity issues on biotech boards.

Want more KPBS news?
Find us on Twitter and Facebook, or sign up for our newsletters.

To view PDF documents, Download Acrobat Reader.